- Home
- CRMD vs PHK Comparison
CRMD vs PHK Comparison
Compare CRMD & PHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$11.61
Company Overview
Basic Information| Metric | CRMD | PHK |
|---|---|---|
| Founded | 2006 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 876.7M | 842.0M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRMD | PHK |
|---|---|---|
| Price | $11.61 | $4.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $17.43 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 491.5K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.61% |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.25 | N/A |
| Revenue | ★ $214,303,672.00 | N/A |
| Revenue This Year | $627.89 | N/A |
| Revenue Next Year | $40.95 | N/A |
| P/E Ratio | $5.10 | ★ N/A |
| Revenue Growth | ★ 1647.67 | N/A |
| 52 Week Low | $5.60 | $4.13 |
| 52 Week High | $17.43 | $5.15 |
Technical Indicators
Market Signals| Indicator | CRMD | PHK |
|---|---|---|
| Relative Strength Index (RSI) | 61.66 | 43.70 |
| Support Level | $10.90 | $4.87 |
| Resistance Level | $12.10 | $4.91 |
| Average True Range (ATR) | 0.50 | 0.02 |
| MACD | 0.24 | 0.00 |
| Stochastic Oscillator | 83.07 | 46.43 |
Price Performance
Historical Comparison CRMD
PHK
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About PHK Pimco High Income Fund
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. Its secondary objective is to seek capital appreciation.